Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

MS&D develops subtype-selective 5-HT1D receptor agonists for migraine

Oct. 15, 1997

Preliminary human evaluation of DMP-543, a potential antidementia agent

Oct. 15, 1997

Role for NGF in Alzheimer's disease?

Oct. 14, 1997

Pierre Fabre discloses potent and selective 5-HT1B receptor antagonists

Oct. 14, 1997

Briana Bio-Tech licenses peptide technology for chronic MS

Oct. 13, 1997

Preclinical data indicate effectiveness of Sertoli cells in neural regeneration

Oct. 13, 1997

Important NRC discovery related to stroke and epilepsy

Oct. 10, 1997

VA-045 effective against TBI-induced retrograde and anterograde amnesia

Oct. 10, 1997

Scios/Wyeth-Ayerst commence large pivotal trials of bFGF for stroke

Oct. 10, 1997

Phase II results for ganaxolone in epilepsy and migraine anticipated by year-end

Oct. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 19, 2025
Lost in trans-lation? Trump’s mouse charge doesn’t click
BioWorld
U.S. President Donald Trump touched off a not-uncommon flurry of puzzlement and outrage when, during his speech to Congress on March 4, he referred to an example...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...